Kindred Biosciences (KIN) Short Interest Ratio & Short Volume

Short interest is the volume of Kindred Biosciences shares that have been sold short but have not yet been closed out or covered. As of August 13th, investors have sold 921,200 shares of KIN short. 2.53% of Kindred Biosciences' shares are currently sold short. Learn More on Kindred Biosciences' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. KIN shares currently have a short interest ratio of 1.0. Learn More on Kindred Biosciences's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.53% of Kindred Biosciences' floating shares are currently sold short.

Kindred Biosciences saw a decline in short interest in August. As of August 13th, there was short interest totaling 921,200 shares, a decline of 5.9% from the previous total of 979,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Kindred Biosciences currently has issued a total of 45,462,000 shares. Some of Kindred Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Kindred Biosciences currently has a public float of 36,410,000 shares.

2.53% of Kindred Biosciences' shares are currently sold short. Here is how the short interest of companies compare to Kindred Biosciences: Zymeworks Inc. (3.24%), Aerovate Therapeutics, Inc. (21.72%), Actinium Pharmaceuticals, Inc. (2.68%), PyroGenesis Canada Inc. (0.16%), Aadi Bioscience, Inc. (6.58%), Eagle Pharmaceuticals, Inc. (0.46%), NanoViricides, Inc. (0.57%), Matinas Biopharma Holdings, Inc. (1.05%), AEON Biopharma, Inc. (3.71%), Spruce Biosciences, Inc. (0.22%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Block, Inc. ($9.67 billion), S&P Global Inc. ($7.87 billion), Advanced Micro Devices, Inc. ($7.80 billion), Analog Devices, Inc. ($7.03 billion), Sea Limited Sponsored ADR ($6.40 billion), Charter Communications, Inc. ($5.60 billion), Wayfair Inc. ($5.18 billion), Aon plc ($3.93 billion), CrowdStrike ($2.52 billion), and Teladoc Health, Inc. ($2.49 billion). View all of the most shorted stocks.

Short selling KIN is an investing strategy that aims to generate trading profit from Kindred Biosciences as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Kindred Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of KIN, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KIN, twice per month. The most recent reporting period available is August, 13 2021.